Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.
about
The protein interacting with C-kinase (PICK1) interacts with and attenuates parkin-associated endothelial-like (PAEL) receptor-mediated cell deathParkin ubiquitinates and promotes the degradation of RanBP2Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cellsIdentification of Heat Shock Protein 60 as a Regulator of Neutral Sphingomyelinase 2 and Its Role in Dopamine UptakeMechanisms of dopamine transporter regulation in normal and disease statesParkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channelsParkin Regulation and Neurodegenerative DisordersTrafficking of the plasma membrane gamma-aminobutyric acid transporter GAT1. Size and rates of an acutely recycling poolBehavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.Monoamine transporters: vulnerable and vital doorkeepers.Electrophilic adduction of ubiquitin activating enzyme E1 by N,N-diethyldithiocarbamate inhibits ubiquitin activation and is accompanied by striatal injury in the rat.Microtubule: a common target for parkin and Parkinson's disease toxins.The ring between ring fingers (RBR) protein familySerine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans.Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder.Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.Regulation of Parkin E3 ubiquitin ligase activity.Protein interacting with C kinase and neurological disorders.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Functional Role of Parkin against Oxidative Stress in Neural Cells.A microfluidic method for dopamine uptake measurements in dopaminergic neurons.BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease.Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling.The synaptic function of parkin.Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux.Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson's disease aetiology.Parkin stabilizes microtubules through strong binding mediated by three independent domains.Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains.iPS cells in the study of PD molecular pathogenesis.Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C.Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway.Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson's Disease.No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPs.
P2860
Q24295004-8B108686-C84F-4456-842F-983A684434FDQ24298223-C6818E8C-2F3F-49E2-9109-70E89BD08AE5Q24304882-115D81EE-3DDB-47AF-B366-DEB08EB425E2Q24307647-8D807F74-601B-4220-B63B-8A3A7EBD0527Q24598750-AFA6B70C-67CB-47CA-8988-A2C14F7FB7C1Q24679424-FC3B119A-9449-41A8-AF2E-F94C151D565AQ26770443-2B7C9D2C-D3A5-41D9-9D09-AB3206C33BBEQ28581638-0C0D94BF-699D-4AE0-9FCF-D5A1FB194B4BQ30444939-05364E72-3D78-4CBA-A612-63CDAE29DD0BQ30479554-158231FF-474D-419C-9D7B-3C703DE5E767Q34079770-54608715-49E6-44F9-84D0-EBCA559132C7Q34528753-10F1866A-7143-4559-A4B2-219B5A803B3CQ34673305-45003E94-C383-4055-BF34-A06AF67860C9Q34858502-5827234A-B525-4455-B047-0F4F463D4179Q35877150-EAF19AC5-DA4F-4583-9B53-1B413F61220EQ36413040-D049941E-670F-4949-AA47-C1CC2B74C147Q36641831-139F59D5-A32C-46C6-A5BA-9A07B588AA61Q36762636-2615D993-8FAE-42D8-B8DF-27BC5EA80F3BQ36887384-642DFD0C-7C35-4E83-B7F5-D58BB0D596F6Q37375576-D88AF66B-A4C8-4CD2-AB8E-1850164C01FFQ37414540-CCEE805A-0DD4-47DA-9B4C-6628584E0F5DQ37509682-02D5B9E0-AC04-4C79-BD8C-AB3FFDBA7151Q38004927-B2C2B538-8529-452C-BCBE-45B4E94D73B1Q38084249-9971FF55-2AF4-483B-9E06-A93087CB4932Q38243174-BFE6A2CF-F712-4B89-AD96-E7DE08C9DE3AQ38563674-AC4E818D-AEB9-4809-8B02-031083F422E4Q38806889-7DBB7E11-6FA0-485C-B8C1-50CFAEE0FDA5Q38967787-32866B0D-45C4-49EF-B538-3CD2A2EF83E0Q39139940-74389447-BB4F-4FE9-A956-95B15651C1D7Q39196417-C99CBE57-127F-447E-BDD6-F9D6BBA77D99Q39415413-415118D4-01E6-4955-A47A-A9D142EE7859Q40049783-C53F7F76-6BCE-41D7-9348-AD2AFD468896Q40452676-18D958B5-1273-416B-AA42-12A5A271ABC2Q43123357-AE8117CD-1E46-4287-A581-EFA501E0F278Q45271574-99F37F4D-E5DD-4AB9-B9BE-E1FA584891F6Q46579323-E38D5FFF-552E-4995-9EE8-533AD40DA5E2Q46658258-4297F39C-76E5-4A5C-B1E3-AE73F8C86F0DQ46958208-1F72E828-2A3B-4D73-81D5-790C76391148Q47313391-9434FB61-CE80-43A7-B6A3-EBE94F4FCB76Q47805564-B3CE4384-FCE1-4960-841C-A9C859035C3C
P2860
Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Parkin increases dopamine upta ...... ssion of dopamine transporter.
@en
type
label
Parkin increases dopamine upta ...... ssion of dopamine transporter.
@en
prefLabel
Parkin increases dopamine upta ...... ssion of dopamine transporter.
@en
P2093
P2860
P356
P1476
Parkin increases dopamine upta ...... ssion of dopamine transporter.
@en
P2093
Houbo Jiang
Qian Jiang
P2860
P304
54380-54386
P356
10.1074/JBC.M409282200
P407
P577
2004-10-18T00:00:00Z